| Title | Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer. | | Author(s) | Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, Sakano S, Ohmi C, Gondo T, Naito K | | Institution | Department of Urology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan. | | Source | BJU Int 2008 May 15. | | Abstract | OBJECTIVES To clarify the significance of lymphovascular invasion (LVI) in patients with pT3N0M0 upper urinary tract (UUT) urothelial carcinoma (UC) relative to prognosis in terms of disease-specific survival, as LVI, which implies both blood vessel and lymph vessel involvement, is reportedly a poor prognostic factor in patients with UUT-UC.
PATIENTS AND METHODS The clinical records of 90 patients who had surgery for UUT-UC were reviewed retrospectively. The median patient age was 71 years and the median follow-up was 42 months. The prognostic significances of LVI (with vs without), T stage (<1 vs 2-4), grade (1-2 vs 3), N stage (0 vs 1-2), age (</=70 vs >70 years), gender and tumour location (renal pelvis vs ureter) for survival time were evaluated.
RESULTS LVI of UUT-UC was found in 34 patients (37.8%). There were significantly higher frequencies of LVI with advancing stage and lymph node metastasis. Kaplan-Meier analysis showed that LVI was strongly associated with disease-specific survival in all patients (P < 0.001) and in patients with pT3N0M0 disease (P < 0.001). Univariate analyses showed that LVI, T stage, N stage and tumour grade were significantly related to disease-specific survival in all patients (P < 0.001, <0.001, 0.003 and 0.007, respectively). Multivariate analysis using Cox proportional hazards model showed that LVI was the only prognostic factor with independent significance for disease-specific survival (P < 0.001).
CONCLUSIONS LVI appears to be an important and independent prognostic factor for UUT-UC in patients treated by nephroureterectomy. Our data suggest that the LVI status might be a predictive marker for disease-specific survival in patients with T3N0M0 UTT-UC. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18485032 |
|
